408 related articles for article (PubMed ID: 19723906)
1. Adherence rates and associations with nonadherence in patients with rheumatoid arthritis using disease modifying antirheumatic drugs.
van den Bemt BJ; van den Hoogen FH; Benraad B; Hekster YA; van Riel PL; van Lankveld W
J Rheumatol; 2009 Oct; 36(10):2164-70. PubMed ID: 19723906
[TBL] [Abstract][Full Text] [Related]
2. Beliefs about medications: a questionnaire survey of people with rheumatoid arthritis.
Neame R; Hammond A
Rheumatology (Oxford); 2005 Jun; 44(6):762-7. PubMed ID: 15741193
[TBL] [Abstract][Full Text] [Related]
3. Patient, disease, and therapy-related factors that influence discontinuation of disease-modifying antirheumatic drugs: a population-based incidence cohort of patients with rheumatoid arthritis.
Maradit-Kremers H; Nicola PJ; Crowson CS; O'Fallon WM; Gabriel SE
J Rheumatol; 2006 Feb; 33(2):248-55. PubMed ID: 16358365
[TBL] [Abstract][Full Text] [Related]
4. Patient decision-making related to antirheumatic drugs in rheumatoid arthritis: the importance of patient trust of physician.
Martin RW; Head AJ; René J; Swartz TJ; Fiechtner JJ; McIntosh BA; Holmes-Rovner M
J Rheumatol; 2008 Apr; 35(4):618-24. PubMed ID: 18278840
[TBL] [Abstract][Full Text] [Related]
5. Providing patients with information about disease-modifying anti-rheumatic drugs: Individually or in groups? A pilot randomized controlled trial comparing adherence and satisfaction.
Homer D; Nightingale P; Jobanputra P
Musculoskeletal Care; 2009 Jun; 7(2):78-92. PubMed ID: 18792423
[TBL] [Abstract][Full Text] [Related]
6. Patterns of disease modifying antirheumatic drug use in a Spanish cohort of patients with rheumatoid arthritis.
Gonzalez-Alvaro I; Carmona L; Balsa A; Sanmarti R; Belmonte MA; Tena X;
J Rheumatol; 2003 Apr; 30(4):697-704. PubMed ID: 12672186
[TBL] [Abstract][Full Text] [Related]
7. Intentional and unintentional nonadherence to ocular hypotensive treatment in patients with glaucoma.
Rees G; Leong O; Crowston JG; Lamoureux EL
Ophthalmology; 2010 May; 117(5):903-8. PubMed ID: 20153902
[TBL] [Abstract][Full Text] [Related]
8. The influence of medication beliefs and other psychosocial factors on early discontinuation of disease-modifying anti-rheumatic drugs.
Wong M; Mulherin D
Musculoskeletal Care; 2007 Sep; 5(3):148-59. PubMed ID: 17590885
[TBL] [Abstract][Full Text] [Related]
9. Retention rates of disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis.
Agarwal S; Zaman T; Handa R
Singapore Med J; 2009 Jul; 50(7):686-92. PubMed ID: 19644623
[TBL] [Abstract][Full Text] [Related]
10. Prescription rheumatology practices among Mexican specialists.
Goycochea-Robles MV; Arce-Salinas CA; Guzmán-Vázquez S; Cardiel-Ríos MH
Arch Med Res; 2007 Apr; 38(3):354-9. PubMed ID: 17350489
[TBL] [Abstract][Full Text] [Related]
11. Medication adherence in patients with rheumatoid arthritis: a critical appraisal of the existing literature.
van den Bemt BJ; Zwikker HE; van den Ende CH
Expert Rev Clin Immunol; 2012 May; 8(4):337-51. PubMed ID: 22607180
[TBL] [Abstract][Full Text] [Related]
12. Assessment of American College of Rheumatology quality criteria for rheumatoid arthritis in a pre-quality criteria patient cohort.
Kahn KL; Maclean CH; Wong AL; Rubenstein LZ; Liu H; Fitzpatrick DM; Harker JO; Chen WP; Traina SB; Mittman BS; Hahn BH; Paulus HE
Arthritis Rheum; 2007 Jun; 57(5):707-15. PubMed ID: 17530663
[TBL] [Abstract][Full Text] [Related]
13. High dose chemotherapy and hematopoietic stem cell transplantation: a study of treatment preference in patients with rheumatoid arthritis and rheumatologists.
Verburg RJ; Mahabali SD; Stiggelbout AM; Sont JK; van Laar JM
J Rheumatol; 2002 Aug; 29(8):1653-8. PubMed ID: 12180724
[TBL] [Abstract][Full Text] [Related]
14. An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists.
van Roon EN; van den Bemt PM; Jansen TL; Houtman NM; van de Laar MA; Brouwers JR
Clin Ther; 2009 Aug; 31(8):1737-46. PubMed ID: 19808132
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic strategies in rheumatoid arthritis over a 40-year period.
Kremers HM; Nicola P; Crowson CS; O'Fallon WM; Gabriel SE
J Rheumatol; 2004 Dec; 31(12):2366-73. PubMed ID: 15570636
[TBL] [Abstract][Full Text] [Related]
16. Patient compliance in rheumatoid arthritis, polymyalgia rheumatica, and gout.
de Klerk E; van der Heijde D; Landewé R; van der Tempel H; Urquhart J; van der Linden S
J Rheumatol; 2003 Jan; 30(1):44-54. PubMed ID: 12508389
[TBL] [Abstract][Full Text] [Related]
17. Determinants of treatment adherence in ethnically diverse, economically disadvantaged patients with rheumatic disease.
Garcia Popa-Lisseanu MG; Greisinger A; Richardson M; O'Malley KJ; Janssen NM; Marcus DM; Tagore J; Suarez-Almazor ME
J Rheumatol; 2005 May; 32(5):913-9. PubMed ID: 15868630
[TBL] [Abstract][Full Text] [Related]
18. Relationships between beliefs about medications and nonadherence to prescribed chronic medications.
Phatak HM; Thomas J
Ann Pharmacother; 2006 Oct; 40(10):1737-42. PubMed ID: 16985088
[TBL] [Abstract][Full Text] [Related]
19. Application of explicit process of care measurement to rheumatoid arthritis: Moving from evidence to practice.
Kahn KL; MacLean CH; Liu H; Rubenstein LZ; Wong AL; Harker JO; Chen WP; Fitzpatrick DM; Bulpitt KJ; Traina SB; Mittman BS; Hahn BH; Paulus HE
Arthritis Rheum; 2006 Dec; 55(6):884-91. PubMed ID: 17139665
[TBL] [Abstract][Full Text] [Related]
20. Methotrexate, hydroxychloroquine, and intramuscular gold in rheumatoid arthritis: relative area under the curve effectiveness and sequence effects.
Hurst S; Kallan MJ; Wolfe FJ; Fries JF; Albert DA
J Rheumatol; 2002 Aug; 29(8):1639-45. PubMed ID: 12180722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
